All posts by: Michael Zand

About Michael Zand

Stem cells might not be a good option for your kid’s sports injury – Miami Herald

Continue reading

2017-06-13 NEWS

Stem cells might not be a good option for your kid’s sports injury
Miami Herald
Over the last several years, we have seen a dramatic increase in interest in regenerative medicine, especially the use of PRP and mesenchymal stem cells to help athletes return to their sport after injury. Yet many patients and caregivers struggle to

Continue reading

2017-06-13 NEWS

Stem cell research could help the infertile
Shanghai Daily (subscription)
SCIENTISTS at Beijing’s Tsinghua University are leading the world in inducing in-vitro differentiation of human embryonic stem cells into follicle-like cells. The breakthrough is expected to help the study of premature ovarian failure and improve

Continue reading

2017-06-13 NEWS

Stem cell research could help the infertile
Shanghai Daily (subscription)
SCIENTISTS at Beijing’s Tsinghua University are leading the world in inducing in-vitro differentiation of human embryonic stem cells into follicle-like cells. The breakthrough is expected to help the study of premature ovarian failure and improve

Continue reading

2017-06-13 NEWS

Stem cell research could help the infertile
Shanghai Daily (subscription)
SCIENTISTS at Beijing’s Tsinghua University are leading the world in inducing in-vitro differentiation of human embryonic stem cells into follicle-like cells. The breakthrough is expected to help the study of premature ovarian failure and improve

Continue reading

2017-06-13 NEWS

WRAL Tech Wire

New frontier in cancer care: Turning blood into living drugs :: Editor’s …
WRAL Tech Wire
Immune therapy is the hottest trend in cancer care and this is its next frontier — creating “living drugs” that grow inside the body into an army that seeks and …

and more »

Continue reading

2017-06-13 NEWS

Altered virus may expand patient recruitment in human gene therapy trials
EurekAlert (press release)
For many patients, participating in gene therapy clinical trials isn’t an option because their immune system recognizes and fights the helpful virus used for treatment. Now, University of Florida Health and University of North Carolina researchers have